H
Harmony Biosciences
Biopharmaceutical company and a member of the Paragon Biosciences corporate family
About Harmony Biosciences
Harmony Biosciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases. The company operates in the healthcare sector, specifically targeting conditions that have limited treatment options. Harmony Biosciences serves patients, healthcare providers, and the broader medical community by bringing breakthrough science within reach. The business model revolves around the research, development, and commercialization of novel medications, generating revenue through the sale of these specialized therapies. The company invests heavily in scientific research to identify new clinical possibilities and advance the treatment landscape for rare neurological disorders.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2020
News
Open roles
Harmony Biosciences in the Plymouth Township ecosystem
The Harmony Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later13 investors entered at this stage
Novo Ventures
Fidelity Investments
Nan Fung Group
Vivo Capital
venBio Partners
Valor Equity Partners
Aisling Capital- CLCRG LP
HBM Healthcare Investments
OrbiMed
Blackstone
JPMorgan Chase & Co
Victory Capital
Source: Dealroom Talent Intelligence.
Patents
32 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Harmony Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
